Provenance du réseau au premier degré de Quan Yuan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
BioSyngen Pte Ltd.
 BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore.
7
| Private Company | Pharmaceuticals: Major | 7 |
Biocheetah Pte Ltd.
 Biocheetah Pte Ltd. Pharmaceuticals: MajorHealth Technology Biocheetah Pte Ltd. develops and commercializes non-invasive and protein-based immunodiagnostic applications. The private company is based in Singapore, Singapore. The Singaporean company was founded by Kian-Chung Lee, Jean-Paul Thiery. Kian-Chung Lee has been the CEO since incorporation.
3
| Private Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Quan Yuan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AGTECH HOLDINGS LIMITED | Wholesale Distributors | Director/Board Member | |
| FERRETTI S.P.A. | Recreational Products | Director/Board Member | |
| CHEMPARTNER PHARMATECH CO.,LTD. | Miscellaneous Commercial Services | Chief Executive Officer | |
CLSA Ltd.
 CLSA Ltd. Investment Banks/BrokersFinance CLSA Ltd. is the Hong Kong-based institutional brokerage subsidiary of CITIC Securities Co., Ltd. (SSE: 600030, SEHK: 6030), a full-service investment bank headquartered in China. Founded in 1986, the firm provides sales and execution services to global investors and corporates. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BOCOM INTERNATIONAL HOLDINGS COMPANY LIMITED | Investment Banks/Brokers | Corporate Officer/Principal | |
CLSA Equity Capital Markets Ltd.
 CLSA Equity Capital Markets Ltd. Investment Banks/BrokersFinance Part of CITIC Securities Co., Ltd., CLSA Equity Capital Markets Ltd. provides investment management services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Corporate Officer/Principal | |
ICEA Capital Ltd.
 ICEA Capital Ltd. Regional BanksFinance Part of Industrial & Commercial Bank of China Ltd., ICEA Capital Ltd. provides banking services. The company is based in Hong Kong, Hong Kong. | Regional Banks | Corporate Officer/Principal | |
Bank of America, NA (Charlotte, North Carolina)
 Bank of America, NA (Charlotte, North Carolina) Major BanksFinance Bank of America, NA engages in the provision of commercial banking services. It offers financing, checking and savings accounts, and investment banking for individual clients. The company was founded on March 1, 1927 and is headquartered in Charlotte, NC. | Major Banks | Corporate Officer/Principal | |
| International University of Japan | College/University | Masters Business Admin | |
| Shanghai International Studies University | College/University | Undergraduate Degree | |
| China Finance Strategies Ltd. | President | ||
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Zhejiang Langhua Pharmaceutical Co., Ltd.
 Zhejiang Langhua Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Langhua Pharmaceutical Co., Ltd. engages in the production and manufacture of active pharmaceutical ingredient and intermediate products. Its products include ciprofloxacin hydrochloride, enrofloxacin, levofloxacin hemihydrate, levofloxacin hydrochloride, spironolactone, zidovudine, canrenone, and ciprofloxacin q-acid. The company was founded in 1986 and is headquartered in Taizhou, China. | Pharmaceuticals: Major | Chairman | |
Lion TCR Pte Ltd.
 Lion TCR Pte Ltd. BiotechnologyHealth Technology Lion TCR Pte Ltd. operates as a clinical-stage biotechnology company. The firm focuses on the development of T cell receptor (TCR)-T cell therapy against life-threatening viral infections and viral-related cancers pertinent in Asia. The company was founded by Li Lietao and Antonio Bertoletti and is headquartered in Singapore. | Biotechnology | Chief Executive Officer | |
| VIVA BIOTECH HOLDINGS | Biotechnology | Founder | |
Shanghai NewMed Medical Co., Ltd.
 Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
SCG Cell Therapy Pte. Ltd.
 SCG Cell Therapy Pte. Ltd. Miscellaneous Commercial ServicesCommercial Services SCG Cell Therapy Pte. Ltd. operates as a development stage company. The company is headquartered in Singapore. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Pharmaceuticals: Major | Director/Board Member | |
| LEPU BIOPHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Hebei Titans Medical Supply Technology Group Co. Ltd.
 Hebei Titans Medical Supply Technology Group Co. Ltd. Medical SpecialtiesHealth Technology Hebei Titans Medical Supply Technology Group Co. Ltd. engages in the manufacture of personal hand protection products. Its products are disposable nitrile gloves and disposable vinyl gloves, which are widely used in medical care, clinical examination, chemical industry, electronics, food processing and other industries. The company was founded by Wen Xin Lu and Wei Dong Liu on February 23, 2011 and is headquartered in Xingtai, China. | Medical Specialties | Director/Board Member | |
| Cfs Global Resources Co. Ltd. | Director/Board Member | ||
| SIRNAOMICS LTD. | Biotechnology | Director/Board Member | |
| China Finance Strategies Investment Holdings Ltd. | Chairman |
Statistiques
Internationale
| Chine | 11 |
| Hong Kong | 9 |
| Singapour | 3 |
| Bermudes | 2 |
| Italie | 2 |
Sectorielle
| Health Technology | 9 |
| Finance | 7 |
| Commercial Services | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 17 |
| Independent Dir/Board Member | 8 |
| Chairman | 6 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Feng Mao Hua | 23 |
| Victor Li Lietao | 2 |
| Frank Wang | 2 |
| Michelle Chen | 1 |
| Feiyu Shen | 1 |
| Wang Liqun | 1 |
| Zhang Qiong | 1 |
| Jean-Paul Thiery | 1 |
| Kian-Chung Lee | 1 |
| Eunice Teo | 1 |
